Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Abstract Using our strongly immunogenic SmT1 SARS-CoV-2 spike antigen platform, we developed antigens based on the Beta & Delta variants of concern (VOC). These antigens elicited higher neutralizing antibody activity to the corresponding variant than comparable vaccine formulations based on the orig...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Bassel Akache, Tyler M. Renner, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, Renu Dudani, Blair A. Harrison, Christian Gervais, Jennifer J. Hill, Usha D. Hemraz, Edmond Lam, Sophie Régnier, Anne E. G. Lenferink, Yves Durocher, Michael J. McCluskie
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Portfolio 2022-10-01
Serie:	npj Vaccines
Accesso online:	https://doi.org/10.1038/s41541-022-00540-7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!